Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F7UB8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,138
Award facts
- Contract value 100% obligated
- $18,137.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,137.94 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors on November 25, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis without set-aside designation, reflecting the contractor's established capability to meet federal pharmaceutical procurement requirements. Performance is to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania by November 26, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its comprehensive pharmaceutical supply portfolio. The company's DLA Troop Support Medical contract functions as a global pharmaceutical support vehicle enabling supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for Enbrel, a specialty rheumatoid arthritis medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements for Defense Health Agency and other federal healthcare systems through flexible contract mechanisms.
Quick answers
Who was awarded contract SPE2DR26F7UB8?
SPE2DR26F7UB8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F7UB8 worth?
The government has obligated $18,138 on SPE2DR26F7UB8.
Is contract SPE2DR26F7UB8 an order under another contract?
Yes. SPE2DR26F7UB8 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UB8 competed?
The extent of competition for SPE2DR26F7UB8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award